MINIMED GROUP, INC. ANNUAL MEETING OF STOCKHOLDERS - MARQETA INC

Financial Performance:

• No financial performance data (revenue, earnings, margins, cash flow, debt, etc.) was disclosed; the transcript is a procedural record of an annual stockholder meeting rather than an operational earnings call.
• Outstanding common stock was recorded at 281,349,931 shares as of the August 11, 2026 record date.

Guidance and Future Outlook:

• No forward guidance, growth projections, or long-term strategic outlooks were provided.
• The only future-oriented action mentioned was the ratification of PwC as the independent registered public accounting firm for the 2027 fiscal year.

Business Segments and Product Lines:

• No information regarding business segments, product lines, new launches, or customer agreements was discussed.
• The meeting agenda focused exclusively on corporate governance matters.

Market and Competitive Landscape:

• No commentary on market trends, competition, or market share was provided.

Risks and Challenges:

• No specific business risks or operational challenges were identified or discussed.

Management Commentary and Tone:

• The tone was strictly administrative and procedural, adhering to corporate governance rules for the 2026 Annual Meeting.
• Management, including CEO Q. Dallara, CFO Chas Spooner, and General Counsel Sheila Denton, facilitated the voting process but did not offer operational commentary.
• The meeting concluded without any stockholder questions being submitted or answered.

Analyst Questions and Answers:

• There were no analyst questions; the transcript notes that "there are no stockholder questions" during both the formal proposal and general question periods.

Other Key Points:

• The meeting took place on August 21, 2026 (based on the notice date), with a record date of August 11, 2026.
• A quorum was established with 278,485,985 shares represented (representing a majority in voting power).
• Four proposals were successfully passed with a plurality or majority vote:
  1. Election of Class I directors: Kevin Lofton, David Endicott, D. Keith Grossman, and Timothy Wicks.
  2. Ratification of PwC as the 2027 independent auditor.
  3. Non-binding advisory vote to approve named executive officer compensation.
  4. Non-binding advisory vote to set the frequency of future say-on-pay votes to every one year.
• Final vote results will be reported via an SEC Form 8-K within four business days.
• The meeting was adjourned following the approval of all proposals.